-
Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients with Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Study
phs003019
-
Genomic Analysis of Nucleic Acid Sequences from Pancreatic Cancer
Study
phs003035
-
Single Cell Genome Variation Induced by Mutational Processes in Cancer - HGSOC Trios Study
Study
phs003036
-
Exploiting New Patterns of Genome Damage in Triple Negative Breast Cancer
Study
phs003038
-
Metastatic Colorectal Adenocarcinoma Tumor Purity Assessment from Whole Exome Sequencing Data
Study
phs003059
-
De Novo Characterization of Cell-Free DNA Fragmentation Hotspots in Plasma Whole-Genome Sequencing
Study
phs003062
-
Phenotypic Signatures of Circulating Neoantigen-Reactive CD8+ T Cells in Patients with Metastatic Cancers
Study
phs003064
-
Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME): A Bladder Cancer Advocacy Network (BCAN)-Led Collaborative Research Pilot Study
Study
phs003066
-
A National Translational Science Network of Precision-Based Immunotherapy for Primary Liver Cancer (PLC)
Study
phs003074
-
Retinoblastoma Aqueous Humor Liquid Biopsy Repository
Study
phs003077